Search Results

You are looking at 1 - 10 of 48 items for :

  • "evidence-based medicine" x
Clear All
Full access

Edward C. Li and Jessica DeMartino

practice is a necessary last step in the evidence-based medicine process of caring for patients. The clinical application of these studies could considerably aid the clinical decision-making process, which currently judges and evaluates the available data

Full access

Margaret Tempero

practice guidelines. The diversity part was a bit trickier. Guidelines and quality care beg for evidence-based medicine to guide the process, and health services research to ensure dissemination and assess outcomes. But at the same time, our ability to

Full access

Margaret Tempero

payers and determinants of cost of care. Evidence-based medicine will always remain best practice, but defining best of care for increasingly small subsets based on molecular, not clinical, findings will be a challenge. As for the business of medical

Full access

-of-care access to the NCCN Guidelines and an ability to incorporate patient-specific factors through novel technology that assists clinical decision-making.” “The collaboration between Proventys and NCCN represents the perfect blend of evidence-based medicine

Full access

Michael A. Kolodziej

comparative effectiveness will actually look like, I asked in exasperation, “As a provider, what do you want me to do?” I offer here a modest proposal for what we can and should do. Commitment to Evidence-Based Medicine The rapid rise in the costs

Full access

Laurie Elit, Gregory R. Pond and Mark N. Levine

Wilkins; 2005 . 7. Laupacis A , Wells , G , Richardson WS , Tugwell P . Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group . JAMA 1994 ; 272 : 234 – 237 . 10.1001/jama.1994

Full access

Fikri İçli, Hakan Akbulut, Shouki Bazarbashi, Mehmet Ayhan Kuzu, Mohandas K. Mallath, Kakil Ibrahim Rasul, Scott Strong, Aamir Ali Syed, Faruk Zorlu and Paul F. Engstrom

colorectal cancer should ideally be based on evidence-based medicine, standardized practices do not exist in other parts of the world. The social, cultural, and economic differences among the countries may be responsible for this lack of standard management

Full access

Patricia J. Goldsmith

. Anchored in clinical quality and evidence-based medicine, Value Pathways powered by NCCN will build on The US Oncology Network's Level I Pathways (discussed in more detail on page 121 ) and help patients receive the highest-quality care with the best

Full access

Margaret Tempero

-cutter approach. Arguably, because of evidence-based medicine, that’s probably the right choice for most patients. But exceptions and outliers always exist. Every day we see patients with certain comorbidities or disease features for whom deviation from a

Full access

Margaret Tempero

. Investigators with fresh ideas are frustrated. And industry, for the most part, would rather conduct its own studies. Fundamentally, well-designed and flawlessly conducted clinical trials that ask important questions are at the core of evidence-based medicine